A pilot study on the application of a symptom-based score for the diagnosis of cow's milk protein allergy

Yvan Vandenplas, Althera Study Group, Philippe Steenhout, Dominik Grathwohl, Yvan Vandenplas, Althera Study Group, Philippe Steenhout, Dominik Grathwohl

Abstract

Objective: A challenge is the recommended test to diagnose cow's milk protein allergy. However, many parents and physicians prefer to not challenge because the procedure may cause (severe) symptoms. In clinical routine, diagnostic testing is only available for IgE-mediated allergy. The aim of this study was to test the diagnostic accuracy of a symptom-based score to select infants at risk of having cow's milk protein allergy.

Methods: A symptom-based score was developed and consensus was reached that a score of ≥12 would select infants at risk of cow's milk protein allergy. Diagnosis of cow's milk protein allergy was demonstrated with a positive challenge after 1-month elimination diet.

Results: An open challenge was performed in 85/116 (73%) infants suspected of cow's milk protein allergy based on a symptom-based score ≥ 12 and was positive in 59/85 (69%). Although "a challenge test" was planned in the protocol, 27% of the parents refused the challenge. The mean decrease after 1 month of elimination diet with an extensive hydrolysate was -8.07 (95% confidence interval = -8.74, -7.40). If the symptom-based score during the elimination diet decreased to 6 or lower, 80% of the infants had a positive challenge test. If the symptom-based score remained >7, the challenge test was positive in only 48% (p < 0.001).

Conclusion: In daily practice, a symptom-based score of ≥12 is a useful tool to select infants at risk of cow's milk protein allergy. If an elimination diet reduces the symptom-based score to ≤6, the challenge test is positive in 80%.

Keywords: Cow’s milk protein allergy; hydrolysate; symptom-based score.

Conflict of interest statement

Declaration of conflicting interests: D.G. and P.S. are employed by Nestlé Nutrition; Y.V. is consultant for Biocodex and United Pharmaceuticals.

References

    1. Boyce JA, Assa’ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 2010; 126 (Suppl. 6): S1–S58.
    1. Koletzko S, Niggemann B, Arato A, et al. Diagnostic approach and management of cow’s milk protein allergy in infants and children: a practical guideline of the GI-committee of ESPGHAN. J Pediatr Gastroenterol Nutr 2012; 55: 221–229.
    1. Rona RJ, Keil T, Summers C, et al. The prevalence of food allergy: a meta-analysis. J Allergy Clin Immunol 2007; 120: 638–646.
    1. Sicherer SH. Epidemiology of food allergy. J Allergy Clin Immunol 2011; 127: 594–602.
    1. Vandenplas Y, Koletzko S, Isolauri E, et al. Guidelines for the diagnosis and management of cow’s milk protein allergy in infants. Arch Dis Child 2007; 92: 902–908.
    1. Eggesbo M, Botten G, Halvorsen R, et al. The prevalence of CMA/CMPI in young children: the validity of parentally perceived reactions in a population-based study. Allergy 2001; 56: 393–402.
    1. Barnett AG, Van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol 2005; 34: 215–220.
    1. Fiocchi A, Brozek J, Schunemann H, et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines. Pediatr Allergy Immunol 2010; 21 (Suppl. 21): S1–S125.
    1. Klemola T, Vanto T, Juntunen-Backman K, et al. Allergy to soy formula and to extensively hydrolyzed whey formula in infants with cow’s milk allergy: a prospective, randomized study with a follow-up to the age of 2 years. J Pediatr 2002; 140: 219–224.
    1. Vandenplas Y, Gottrand F, Veereman-Wauters G, et al. Gastro-intestinal manifestations of cow’s milk protein allergy and gastro-intestinal motility. Acta Paediatr 2012; 101: 1105–1109.
    1. Schouten B, Van Esch BCAM, Kormelink TG, et al. Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy. Pediatr Allergy Immunol 2011; 22: 537–542.

Source: PubMed

3
订阅